Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

HUMA

HUMA News

Newswire

13:02

BTIG Reiterates Humacyte Buy Recommendation, Sees 615.56% Upside Potential

06:17

Humacyte: BTIG Raises PT to $6, Reiterates Buy Rating

09:35

Humacyte: Boral Capital raises PT to $25 from $25, maintains Buy rating.

08:09

Humacyte presents positive ATEV outcomes for dialysis patients, arterial trauma.

13:46

Humacyte: Benchmark maintains Buy, PT down to $11 from $14.

View More

About HUMA

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More